The Fauci Files, Part 2 — The Money: Who Paid for the Work, and Why They Were So Sure So Fast

In Part 1 we left the question standing in the middle of the room. If the tools to build a traceless coronavirus existed, and the lab at the center of the story did that kind of work, then "no fingerprints, therefore natural" was never an argument at all. It was a statement about what could not be seen.

Which raises a different question, and a more human one.

Why were some of the most credentialed people in the field so certain, so quickly, that no laboratory could possibly be involved?

Certainty is expensive. It costs you the ability to change your mind later without looking foolish. Scientists, as a rule, hate spending it early — they hedge, they wait for data, they say "we cannot yet exclude." So when a group of them spends that certainty in the first weeks of a pandemic, on a question the data could not yet answer, the interesting move is not to argue with them. It is to ask what they were buying with it.

Follow the money and the answer is not hidden. It is on a grant.

The chain runs like this, and every link is a document. The National Institute of Allergy and Infectious Diseases — the agency Anthony Fauci ran for thirty-eight years — awarded a grant to a New York nonprofit called EcoHealth Alliance, run by a zoologist named Peter Daszak. EcoHealth, in turn, subcontracted part of that money to a laboratory on the other side of the world: the Wuhan Institute of Virology, to study bat coronaviruses. This is not an allegation from a message board. The grant number is public, the dollar figures are in the NIH's own database, and the arrangement is described in the NIH's own letters to Congress.

Hold that structure in your head, because the structure is the story.

The man who ran the U.S. agency that funded the work. The nonprofit that passed the money through. The lab that did the experiments.

Now add the fact from Part 1's coda: the loudest early voice insisting the virus was natural — the organizer of the February 2020 Lancet statement that branded lab-leak questions a "conspiracy theory" — was Peter Daszak. The grantee. The man whose own program would be implicated if the answer turned out to be the lab.

I want to name what I am not saying, because this is where the story usually breaks.

I am not saying these men engineered a virus. I am not saying they knew where it came from. I am not even saying they were wrong.

I am saying something narrower and harder to wave off: the people best positioned to shut down the lab-leak question were also the people with the most to lose if it were ever taken seriously. When the funder, the middleman, and the beneficiary of a line of research are the ones assuring you that research could not possibly be involved, you have not found a conspiracy. You have found a conflict of interest. Those are different things, and the difference matters — a conflict of interest does not tell you the conclusion is wrong. It tells you who was not a neutral party, and it disqualifies their certainty, not their facts.

Which brings us to the word the entire dispute has been fought over.

Gain of function.

In 2021, under questioning, Fauci told Congress — categorically — that the NIH "has not ever and does not now fund gain-of-function research in the Wuhan Institute of Virology." Categorically is a strong word. It is the word you use when you want a sentence to close a door.

Then, in October 2021, the NIH's own principal deputy director, Lawrence Tabak, sent Congress a letter. It disclosed that one of the EcoHealth-funded experiments had produced a modified bat coronavirus that made humanized mice sicker than the original. And in the same breath, Tabak's letter insisted this "did not meet the NIH's definition of gain-of-function research" — because the U.S. government's 2017 oversight framework defines the regulated category narrowly, reserving it for work on pathogens already shown to be dangerous to humans.

So here is the honest picture, and it does not flatter either side.

The natural-origin defense has a real point, and I will give it its due: "gain of function" is not a slur, it is a regulatory term with a specific, narrow legal meaning, and by that meaning it is genuinely arguable that the funded experiments did not qualify. Credentialed virologists split on it in good faith — Rutgers' Richard Ebright reads the disclosed work as gain-of-function; Angela Rasmussen reads it as falling outside the definition. FactCheck.org, reviewing the same letter, found no evidence that Fauci "knowingly" lied. That is a fact, and I print it.

But two things can be true at once, and both are.

A statement can be technically defensible and still be built to mislead. "We did not fund gain-of-function research" can be accurate under a narrow regulatory definition and, at the same time, leave a listener with a false picture — that no U.S.-funded work in Wuhan involved making a coronavirus more dangerous, when a U.S.-funded experiment there had done exactly that, by the letter's own account. The defense is not that nothing worrying happened. The defense is that the worrying thing does not fit the paperwork's definition of worrying.

That is not the answer of a man with nothing to hide. It is the answer of a man who wrote the rulebook getting to grade his own exam by it.

And now step back and see the shape of the whole thing, because the shape is what the individual arguments keep you from seeing.

A federal agency funds a category of research whose risks are real enough that the government built a special oversight framework for it. The framework's definitions are narrow enough that a great deal of the actual risky work falls just outside them. The same agency that funds the work also helps decide what counts as regulated. And when the worst-case question arrives — did this research cause the pandemic? — the people inside that loop are the ones who get to tell the public whether the question is even legitimate.

That is not a story about one man lying to Congress. It might not include a single provable lie. It is a story about a system in which the referee, the team owner, and the star player are the same three people, and we were asked to accept their word that the game was clean.

The money explains the incentive. It explains why the certainty came early and loud, and from exactly the quarter with the most exposure.

What it does not yet explain is how that incentive was converted into something the rest of us experienced as settled science — how a conflicted man's press release became, for two years, the thing you were not allowed to question.

That conversion has a paper trail too.

It is the subject of Part 3.